Compulsory License season now.
Indian companies started exploring CL as an option to market drugs which are patented in India. (Whichever product patents granted on 2007-2008, are subject of CL now)
|Product/Innovator||Indian Patent No||Date of Grant||Applied by|
|Sorafenib/ Bayer||215758 (IN/PCT/2001/799/MUM)||28/03/2008||Natco is awardedCL for sorafenib|
This list will be updated, as and when there is some news available.